SCHEMBL1629796

SCHEMBL1629796

[O]C(=O)c1ccoc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8866037 0.81 TRPA1 (0.48)
SCHEMBL142183 0.79
SCHEMBL5945922 0.77
SCHEMBL826974 0.77
SCHEMBL7912 0.77
SCHEMBL277930 0.77
SCHEMBL19159706 0.77
SCHEMBL11550514 0.77
SCHEMBL2000883 0.77
Hydrochloric Acid SCHEMBL4253131 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 57 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160185743-A1 15-Oxospiramilactone Derivatives, Preparation Method and Uses Thereof CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2016-06-30 US claimed
EP-2351753-B1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NF kB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT YAKULT HONSHA KK (JP) 2015-02-11 EP claimed
US-8569327-B2 Phenanthroindolizidine derivative and NFκB inhibitor containing same as active ingredient KABUSHIKI KAISHA YAKULT HONSHA (JP) 2013-10-29 US claimed
US-20110201637-A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFKB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT KABUSHIKI KAISHA YAKULT HONSHA (JP) 2011-08-18 US claimed
EP-2351753-A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NF B INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT Kabushiki Kaisha Yakult Honsha (JP) 2011-08-03 EP claimed
CN-1294142-C 17 beta-thiocarboxylate 17 alpha-arylcarbonyloxyandrostane derivatives as anti-inflammatory agents GLAXO GROUP LTD (GB) 2007-01-10 CN claimed
CN-1468253-A 17 beta-thiocarboxylate 17 alpha-arylcarbonyloxyandrostane derivatives as anti-inflammatory agents 2004-01-14 CN claimed
US-5143936-A Benzopyran compound and its pharmaceutical use YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1992-09-01 US claimed
WO-2023210623-A1 HALOALKYL SULFONE ANILIDE COMPOUND AND HERBICIDE CONTAINING SAME 株式会社エス・ディー・エス バイオテック 2023-11-02 WO disclosed
EP-2491915-B1 EASILY REMOVABLE CURABLE COMPOSITION FOR DENTAL USE SUN MEDICAL CO LTD (JP) 2019-07-03 EP disclosed
US-10112918-B2 15-oxospiramilactone derivatives, preparation method and uses thereof KUNMING INSTITUTE OF BOTANY, THE CHINESE ACADEMY OF SCIENCES (CN) 2018-10-30 US disclosed
US-20160185743-A1 15-Oxospiramilactone Derivatives, Preparation Method and Uses Thereof CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2016-06-30 US disclosed
EP-2351753-B1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NF kB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT YAKULT HONSHA KK (JP) 2015-02-11 EP disclosed
US-8569324-B2 Potentiator for radiation therapy comprising pyridine derivative as active ingredient TAIHO PHARMACEUTICAL CO., LTD. (JP) 2013-10-29 US disclosed
US-4749804-A Preparation of stereoisomers of ketals SYNTEX (U.S.A.) INC. (US) 1988-06-07 US disclosed
US-4698339-A BETA-LACTAMASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-10-06 US disclosed
EP-0226896-A2 Lankacidin derivatives and production thereof Takeda Chemical Industries, Ltd. (JP) 1987-07-01 EP disclosed
US-4605758-A Preparation of α-arylalkanoic acids SYNTEX PHARMACEUTICALS INTERNATIONAL LTD. (BM) 1986-08-12 US disclosed
EP-0137403-A2 Carbapenems, their production and use Takeda Chemical Industries, Ltd. (JP) 1985-04-17 EP disclosed
EP-0081993-A2 Optically active alpha-substituted aryl ketones, their preparation and their use in preparing alpha-arylalkanoic acids SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) 1983-06-22 EP disclosed